Is LDOS a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Large backlog and revenue visibility, with revenue (ttm) at ~$17.5B. The bear case rests on the overwhelming majority of Leidos revenue comes from the U.S. Analysts covering it are spread from $110.00 to $225.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The overwhelming majority of Leidos revenue comes from the U.S. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $110.00, -5.2% from the $115.99 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Large backlog and revenue visibility. Leidos ended its most recent quarter with total backlog of roughly $48 billion, giving multi-year visibility into future revenue. The most optimistic analyst target on LDOS is $225.00, +94.0% from the $115.99 price. That figure is only reachable if this thesis works close to its best case.

The overwhelming majority of Leidos revenue comes from the U.S. government, so budget delays, continuing resolutions, sequestration scenarios, and shifting administration priorities can directly pressure results. Contracts are frequently recompeted, and losing a large program or seeing an award protested can create lumpy revenue swings. Margins can be squeezed on fixed-price and cost-reimbursable work if execution slips or labor costs rise. The company also faces growing competition from both traditional peers and large commercial cloud and AI firms moving into federal work. Finally, its modest valuation reflects limited growth, so multiple expansion is not guaranteed even if execution stays solid. The most pessimistic published target is $110.00, -5.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Leidos Holdings is a large government services and technology contractor that builds and runs mission systems for U.S.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Large backlog and revenue visibility) stalling in the reported numbers rather than in the narrative, the risk above (the overwhelming majority of Leidos revenue comes from the U.S) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Leidos is a government services and technology contractor. It builds and operates mission systems for U.S. federal agencies and allied governments across intelligence and digital modernization, cybersecurity, defense systems, homeland security screening, and health services such as medical exams and health IT.

It is often grouped with defense and government services stocks because most of its revenue comes from the U.S. government, including the Department of Defense and intelligence agencies. However, it also has meaningful civil and health work, so it is broader than a pure weapons or platform maker.

Leidos earns revenue primarily through long-duration contracts with U.S. government agencies, structured as cost-reimbursable, time-and-materials, and fixed-price work. It recognizes revenue as it delivers services and systems, and it maintains a large multi-year backlog that provides forward visibility.